Physician profile
John Bollich
NPI 1437769593
$4,790.67
in general payments reported to CMS, 2019-2025
17 companies · $1,012 in 2025
The $1,012 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $84.41 · 2021: $458 · 2022: $1,203 · 2023: $1,158 · 2024: $875 · 2025: $1,012.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,962 · Entertainment: $83.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,961.90 |
| Entertainment | $83.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $990.11 | 2021-2025 | Tryptyr, Precision7, Hydrus Microstent |
| Coopervision INC. | $960.78 | 2021-2025 | Clariti Contact Lens, Biofinity Contact Lens, Myday Contact Lens |
| Rxsight INC | $655.38 | 2022-2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Glaukos Corporation | $262.87 | 2021-2025 | Photrexa Viscous and Photrexa |
| Allergan, INC. | $227.03 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $218.78 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $208.43 | 2023-2024 | |
| Mallinckrodt Hospital Products INC. | $194.11 | 2022 | |
| Oyster Point Pharma, INC. | $190.84 | 2022-2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $180.23 | 2022-2025 | |
| Abbvie INC. | $138.53 | 2022 | |
| Dompe US, INC. | $127.09 | 2024-2025 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $123.39 | 2021-2023 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $107.22 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $105.63 | 2022-2025 | Infuse |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $83.65 | 2023-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Johnson & Johnson Surgical Vision, INC. | $16.60 | 2025 | Tecnis Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bollich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.